• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2022 Fiscal Year Final Research Report

Role of TRPV4 in interstitial cystitis/bladder pain syndrome

Research Project

  • PDF
Project/Area Number 20K09228
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 55050:Anesthesiology-related
Research InstitutionTohoku Medical and Pharmaceutical University

Principal Investigator

Yoshizumi Masaru  東北医科薬科大学, 薬学部, 講師 (70553379)

Project Period (FY) 2020-04-01 – 2023-03-31
Keywords間質性膀胱炎 / 膀胱痛症候群 / LPS / TRPV4 / 炎症性サイトカイン / マクロファージ
Outline of Final Research Achievements

We investigated the potential benefit of intravesical TRPV4 agonist for painful bladder hypersensitivity produced by a rat model of LPS-induced cystitis and whether its effects modulate the LPS signal for cytokine release and macrophage phenotype change. The increased bladder pain-related behaviors and voiding frequency caused by LPS were suppressed by concurrent injection into the rat bladder of a selective TRPV4 agonist, GSK1016790A. Moreover, the production and secretion of proinflammatory cytokines (e.g., CXCL1, CXCL10), are suppressed by the presence of GSK1016790A. Furthermore, TRPV4 activation switched the LPS-stimulated pro-inflammatory M1-type macrophage to the anti-inflammatory M2-type macrophage. These results suggest that that activation of TRPV4 in bladder regulates the proinflammatory response by LPS, and TRPV4 functions may be a promising future therapeutic target for refractory chronic cystitis.

Free Research Field

神経科学

Academic Significance and Societal Importance of the Research Achievements

間質性膀胱炎・膀胱痛症候群は原因が未だ不明であり、治療には膀胱水圧拡張術や50%DMSO膀胱内注入療法があるが、治療効果は一時的でしばしば再燃するため根治治療が急務となる。本研究は、膀胱に局在するTRPV4がLPS誘発性の炎症反応に対して抗炎症へと働くことが確認できた。本研究結果により、TRPV4アゴニストが間質性膀胱炎・膀胱痛症候群に対する新規治療の候補として今後期待できる。

URL: 

Published: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi